lacosamide

The medicine is used to treat epilepsy in adults, adolescents, and children (depending on the type of seizures). It helps to reduce the number of seizures.

Form: solution for infusion

ATC: N03AX18

Manufacturer: Fresenius Kabi Deutschland GmbH Labesfal - Laboratórios Almiro, S.A.

The medicine is used to reduce the number of seizures in adults, adolescents, and children (from 2 or 4 years of age, depending on the type of epilepsy). It helps in the treatment of partial seizures and initially generalized tonic-clonic seizures.

Form: tablets, film-coated

ATC: N03AX18

Manufacturer: Combino Pharm (Malta) Ltd, Galenica Pharmaceutical Industry S.A., Glenmark Pharmaceuticals s.r.o., SVUS Pharma a.s.

The medicinal product is used to reduce the number of seizures in adults, adolescents, and children (from 2 years of age) suffering from epilepsy with partial seizures. It may also be used in children from 4 years of age for the treatment of primarily generalized tonic-clonic seizures.

Form: tablets, film-coated

ATC: N03AX18

Manufacturer: Combino Pharm (Malta) Ltd, Galenica Pharmaceutical Industry S.A., Glenmark Pharmaceuticals s.r.o., SVUS Pharma a.s.

The medicine is used to reduce the number of seizures in adults, adolescents, and children (from 2 or 4 years of age, depending on the type of epilepsy). It helps in the treatment of partial seizures and initially generalized tonic-clonic seizures.

Form: tablets, film-coated

ATC: N03AX18

Manufacturer: Combino Pharm (Malta) Ltd, Galenica Pharmaceutical Industry S.A., Glenmark Pharmaceuticals s.r.o., SVUS Pharma a.s.

The medicine is used to reduce the number of seizures in adults, adolescents, and children (depending on the type of epilepsy). It helps in the treatment of partial seizures and initially generalized tonic-clonic seizures.

Form: tablets, film-coated

ATC: N03AX18

Manufacturer: Combino Pharm (Malta) Ltd, Galenica Pharmaceutical Industry S.A., Glenmark Pharmaceuticals s.r.o., SVUS Pharma a.s.

The medicinal product is used to reduce the number of seizures in adults, adolescents, and children (depending on the type of epilepsy). It helps in the treatment of partial seizures and initially generalized tonic-clonic seizures.

Form: tablets, film-coated

ATC: N03AX18

Manufacturer: Merckle GmbH Teva Pharmaceutical Works Ltd. Teva Operations Poland Sp. z o.o.

The medicine is used to reduce the number of seizures in adults, adolescents, and children (depending on the type of epilepsy). It is used in the treatment of partial seizures and primarily in the treatment of initially generalized tonic-clonic seizures.

Form: tablets, film-coated

ATC: N03AX18

Manufacturer: Merckle GmbH Teva Pharmaceutical Works Ltd. Teva Operations Poland Sp. z o.o.

The medicine is used to reduce the number of seizures in adults, adolescents, and children (from 2 or 4 years of age, depending on the type of epilepsy). It helps in the treatment of partial seizures and initially generalized tonic-clonic seizures.

Form: tablets, film-coated

ATC: N03AX18

Manufacturer: Merckle GmbH Teva Pharmaceutical Works Ltd. Teva Operations Poland Sp. z o.o.

The medicine is used to treat epilepsy in adults, adolescents, and children (depending on the type of seizures) to reduce their frequency.

Form: tablets, film-coated

ATC: N03AX18

Manufacturer: Merckle GmbH Teva Pharmaceutical Works Ltd. Teva Operations Poland Sp. z o.o.

The medicine is used to reduce the number of seizures in adults, adolescents, and children (depending on the type of epilepsy). It may be used alone or in combination with other anti-epileptic drugs.

Form: tablets, film-coated

ATC: N03AX18

Manufacturer: Delorbis Pharmaceuticals Ltd., G.L. Pharma GmbH

The medicine is used to reduce the number of seizures in adults, adolescents, and children (depending on the type of epilepsy). It helps in the treatment of partial seizures and primarily generalized tonic-clonic seizures.

Form: tablets, film-coated

ATC: N03AX18

Manufacturer: Delorbis Pharmaceuticals Ltd., G.L. Pharma GmbH

The medicine is used to reduce the number of seizures in adults, adolescents, and children (from 2 or 4 years of age, depending on the type of epilepsy). It helps in the treatment of partial seizures and primarily in the treatment of initially generalized tonic-clonic seizures.

Form: tablets, film-coated

ATC: N03AX18

Manufacturer: Delorbis Pharmaceuticals Ltd., G.L. Pharma GmbH

Trelema is used in the treatment of epilepsy to reduce the number of seizures. It may be used alone or in combination with other anti-epileptic drugs.

Form: tablets, film-coated

ATC: N03AX18

Manufacturer: Delorbis Pharmaceuticals Ltd., G.L. Pharma GmbH

Trelema is used to reduce the number of seizures in adults, adolescents, and children (from 2 years of age) suffering from partial epilepsy, and in persons (from 4 years of age) with primarily generalized tonic-clonic seizures.

Form: solution for infusion

ATC: N03AX18

Manufacturer: G.L. Pharma GmbH

The medicine is used to reduce the number of seizures in adults, adolescents, and children (from 2 years of age) suffering from partial epilepsy, and in persons (from 4 years of age) with primarily generalized tonic-clonic seizures.

Form: syrup

ATC: N03AX18

Manufacturer: G.L. Pharma GmbH

The medicine is used to reduce the number of seizures in adults, adolescents, and children (from 2 years of age) in the case of epilepsy with partial seizures. It may also be used in combination with other medicines in children from 4 years of age for the treatment of primarily generalized tonic-clonic seizures.

Form: tablets, film-coated

ATC: N03AX18

Manufacturer: Delorbis Pharmaceuticals Ltd., G.L. Pharma GmbH